首页> 外文OA文献 >623 – Ser-287, an Investigational Microbiome Therapeutic, Induces Widespread Transcriptional Changes Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild-To-Moderate Ulcerative Colitis

【2h】

623 – Ser-287, an Investigational Microbiome Therapeutic, Induces Widespread Transcriptional Changes Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild-To-Moderate Ulcerative Colitis

机译：623 - SER-287，一种研究微生物组治疗，诱导有效的患者的安慰剂对照，双盲随机试验（Seret-101）中临床缓解有关的广泛转录变化，患者有活性轻度至中度溃疡性结肠炎

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Liyang Diao; Mauris C. Nnamani; Edward OBrien; Christopher Desjardins; Asuncion Martinez; Sheri Simmons; Kevin Litcofsky; Babara McGovern; Sherry Weigand; David Cook; Jennifer R. Wortman; Matthew R. Henn;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. [J] . Sandborn WJ, Kamm MA, Lichtenstein GR, Alimentary pharmacology & therapeutics. . 2007,第2期

机译：MMX多基质系统美沙拉嗪用于诱导轻度至中度溃疡性结肠炎患者的缓解：两项随机，双盲，安慰剂对照试验的组合分析。
2. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study [J] . Makoto Naganuma, Nobuo Aoyama, Tomohiro Tada, Journal of gastroenterology . 2018,第4期

机译：完全粘膜治疗远端病变诱导的两次水果苷2-mg泡沫促进临床缓解温和至中等溃疡性结肠炎，远端活性炎症：双盲，随机研究
3. Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study [J] . Makoto Naganuma, Nobuo Aoyama, Tomohiro Tada, Journal of gastroenterology . 2018,第4期

机译：校正：通过两次癌症2-mg泡沫诱导的远端病变的完全粘膜愈合促进了临床缓解温和至中等溃疡性结肠炎的远端活性炎症：双盲，随机研究
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. A Phase 2a Multicenter Randomized Double-Blind Parallel-Group Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis [O] . Gionata Fiorino, Giacomo Carlo Sturniolo, Fabrizio Bossa, 2019

机译：IBD98-M延迟释放胶囊的2a期多中心随机双盲平行组安慰剂对照试验可减轻活动性和轻度至中度溃疡性结肠炎患者的病情。
6. A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis [O] . Gionata Fiorino, Giacomo Carlo Sturniolo, Fabrizio Bossa, 2019

机译：IBD98-M延迟粘膜的相2A，多中心，随机，双盲，并联，安慰剂对照试验，以诱导活性和轻度至中度溃疡性结肠炎患者的缓解

623 – Ser-287, an Investigational Microbiome Therapeutic, Induces Widespread Transcriptional Changes Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild-To-Moderate Ulcerative Colitis

著录项

相似文献

相关主题

期刊订阅